Literature DB >> 3729635

Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital.

A J Morrison, R P Wenzel.   

Abstract

From 1975 through 1984, 473 cases of enterococcal nosocomial urinary tract infection (UTI) were identified by prospective hospital-wide surveillance at the University of Virginia Hospital, Charlottesville. The rate of infection increased progressively from 12.3 to 32.2 cases per 10 000 patient discharges, and the proportion of nosocomial UTIs due to this organism increased from 6% to 16%. During the study period, crude mortality was 15%. Patients with the diagnosis of neurogenic bladder accounted for 26% of cases and had a crude mortality of 7.3%; all other cases (74%) had a crude mortality of 18.1%. Risk factors associated with fatal outcome in cases having a nosocomial enterococcal UTI included age of more than 50 years, concurrent acute respiratory failure, hospitalization on the internal medicine service, and concurrent gastrointestinal hemorrhage. Enterococcus is the second most frequent cause of nosocomial UTI in our hospital. The emergence of this pathogen may reflect, in part, its selective advantage imparted by resistance to cephalosporin antibiotics.

Entities:  

Mesh:

Year:  1986        PMID: 3729635

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  29 in total

1.  Characterization of enterococcal isolates by restriction enzyme analysis of genomic DNA.

Authors:  P A Lacoux; J Z Jordens; C M Fenton; M Guiney; T H Pennington
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

2.  The rapid emergence of high level gentamicin resistance in enterococci.

Authors:  K R Forward; J K Kennedy; P A Degagne; K R Bartlett; G K Harding
Journal:  Can J Infect Dis       Date:  1990

Review 3.  Pathogenicity of the enterococcus in surgical infections.

Authors:  P S Barie; N V Christou; E P Dellinger; W R Rout; H H Stone; J P Waymack
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

Review 4.  Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.

Authors:  R C George; A H Uttley
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study.

Authors:  Kristian Karlović; Jadranka Nikolić; Jurica Arapović
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

6.  Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.

Authors:  A I Hoepelman; L J Bakker; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects.

Authors:  J Janifer; S Geethalakshmi; K Satyavani; V Viswanathan
Journal:  Indian J Nephrol       Date:  2009-07

8.  Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.

Authors:  S M Donabedian; J W Chow; J M Boyce; R E McCabe; S M Markowitz; P E Coudron; A Kuritza; C L Pierson; M J Zervos
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice.

Authors:  Esther Heikens; Masja Leendertse; Lucas M Wijnands; Miranda van Luit-Asbroek; Marc J M Bonten; Tom van der Poll; Rob J L Willems
Journal:  BMC Microbiol       Date:  2009-01-29       Impact factor: 3.605

10.  First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia.

Authors:  Diana Panesso; Sigifredo Ospina; Jaime Robledo; María Claudia Vela; Julieta Peña; Orville Hernández; Jinnethe Reyes; César A Arias
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.